David F. Wiemer
University of Iowa
280 Papers
2.7K Citations
David F. Wiemer is an academic researcher from University of Iowa. The author has contributed to research in topics: Phosphonate & Chemistry. The author has an hindex of 38, co-authored 271 publications. Previous affiliations of David F. Wiemer include University of California, San Diego & Cornell University.
Chat about Author
Papers
Prodrugs of Phosphonates and Phosphates: Crossing the Membrane Barrier
Andrew J. Wiemer,David F. Wiemer +1 more
TL;DR: This chapter presents recent studies on advances in prodrug forms, along with representative examples of their application to marketed and developmental drugs.
An antifungal terpenoid defends a neotropical tree (Hymenaea) against attack by fungus-growing ants (Atta).
TL;DR: Caryophyllene epoxide is tested for antifungal activity and found that it is an extremely potent compound, not only against the attine fungus, but other fungi as well.
116
Phosphonate and bisphosphonate analogues of farnesyl pyrophosphate as potential inhibitors of farnesyl protein transferase.
TL;DR: Several phosphonate and bisphosphonate analogues of farnesyl pyrophosphate have been prepared for an examination of their ability to inhibitFarnesyl protein transferase (FPTase).
100
Synthesis of a phosphoantigen prodrug that potently activates Vγ9Vδ2 T-lymphocytes.
Chia-Hung Christine Hsiao,Xiaochen Lin,Rocky J. Barney,Rebekah R. Shippy,Jin Li,Olga Vinogradova,David F. Wiemer,Andrew J. Wiemer +7 more
TL;DR: The pivaloyloxymethyl prodrug is the most potent phosphoantigen described to date, with stronger stimulation of Vγ9Vδ2 T cells from human peripheral blood and greater ability to induce lysis of Daudi lymphoma cells relative to the previously most potent compound, (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP).
99